v3.24.2.u1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 6 Months Ended
Jul. 31, 2024
Jul. 31, 2023
Operating activities    
Net income $ 92,954 $ 8,975
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 88,936 56,184
Amortization of intangible assets 12,332 8,276
Amortization of deferred contract acquisition costs 147,851 112,877
Non-cash operating lease cost 7,167 6,331
Stock-based compensation expense 384,002 295,633
Deferred income taxes (1,929) (352)
Realized gains on strategic investments (6,227) 0
Non-cash interest expense 1,785 1,531
Accretion of short-term investments purchased at a discount 2,285 0
Changes in operating assets and liabilities, net of impact of acquisitions    
Accounts receivable, net 192,060 86,718
Deferred contract acquisition costs (158,333) (122,007)
Prepaid expenses and other assets (63,224) (26,338)
Accounts payable (72) (2,982)
Accrued expenses and other liabilities 7,968 4,935
Accrued payroll and benefits (29,432) (30,161)
Operating lease liabilities (7,113) (6,475)
Deferred revenue 38,859 152,528
Net cash provided by operating activities 709,869 545,673
Investing activities    
Purchases of property and equipment (88,937) (102,681)
Capitalized internal-use software and website development costs (24,995) (25,975)
Purchases of strategic investments (2,702) (12,177)
Proceeds from sales of strategic investments 10,895 0
Business acquisitions, net of cash acquired (96,381) 0
Purchases of intangible assets 0 (500)
Proceeds from maturities and sales of short-term investments 97,300 250,000
Purchases of deferred compensation investments (1,209) (876)
Proceeds from sales of deferred compensation investments 41 0
Net cash (used in) provided by investing activities (105,988) 107,791
Financing activities    
Proceeds from the issuance of common stock upon exercise stock options 2,464 4,125
Proceeds from issuance of common stock under the employee stock purchase plan 56,099 45,432
Distributions to non-controlling interest holders (4,085) 0
Capital contributions from non-controlling interest holders 5,500 8,088
Net cash provided by financing activities 59,978 57,645
Effect of foreign exchange rates on cash, cash equivalents and restricted cash (1,040) 1,083
Net increase in cash, cash equivalents and restricted cash 662,819 712,192
Cash, cash equivalents and restricted cash at beginning of period 3,377,597 2,456,924
Cash, cash equivalents and restricted cash at end of period 4,040,416 3,169,116
Cash and cash equivalents 4,038,536 3,167,215
Restricted cash included in prepaid expenses and other assets 1,880 1,901
Total cash, cash equivalents and restricted cash shown in the condensed consolidated statements of cash flows 4,040,416 3,169,116
Supplemental disclosure of cash flow information:    
Interest paid 11,250 11,250
Income taxes paid, net of refunds received 10,250 9,991
Supplemental disclosure of non-cash investing and financing activities:    
Net decrease in property and equipment included in accounts payable and accrued expenses (16,469) (20,089)
Equity consideration for acquisitions 468 0
Operating lease liabilities arising from obtaining operating right-of-use assets 2,854 13,083
Purchases of intangible assets included in accrued expenses and other liabilities 0 26
Proceeds from sales of strategic investments not yet received 4,808 0
Stock-based compensation included in capitalized software development costs and fixed assets 19,478 16,000
Noncash consideration for the purchase of strategic investments 3,319 0
Noncash consideration received from sales of strategic investments $ 3,319 $ 0